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Formation of high-affinity antibodies towards antigens is ensured with a process called 
somatic hypermutation, which happens during affinity maturation of activated B-cells. 
During this process point mutations are introduced to variable regions of rearranged 
immunoglobulin genes. Activation-induced cytidine deaminase (AID) is the key enzyme 
in somatic hypermutation and it deaminates deoxycytidines in single-stranded DNA into 
deoxyuridine causing mutations. AID preferably binds structured instead of linear DNA 
and G-quadruplexes (G4s) can potentially be such structures. G-quadruplexes are formed 
when four guanines interact via Hoogsteen hydrogen bonds and rearrange into co-planar 
G-quartets which when stacked form the quadruplex structure. The purpose of this study 
was to find out if these G4s are connected to targeting of somatic hypermutation. 
 
The research was done using GFP-based reporters in chicken DT40 B-cell lines. The cells 
were studied by flow cytometry in GFP reporter assay and by sequencing. Results from 
the study indicate that G4s could have an effect in targeting of somatic hypermutation. 
Removing the already existing G4s significantly reduced somatic hypermutation and 
changed the locations of mutations. In contrary, adding a strong G4 increased somatic 
hypermutations but the difference was not statistically significant. However, also in this 
case, sequencing showed a shift in the locations of mutations towards the G4 structure 
and an increase in the mutations around the area where the G4 was added. 
 
The results suggest that when the requirements of locus-specific targeting of somatic 
hypermutation are met, G4s play a role in determining the exact locations of mutations 
within the gene.  
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1.1 B lymphocyte development and formation of antibody repertoire 
B cells are essential for the normal functioning of the human immune system and the 
protection of the body against thousands of pathogens. They get their name as they are 
derived from the bone marrow or the bursa of Fabricius in birds in comparison to T cells 
that are derived from the thymus. In short B cells are a group of cells that express 
immunoglobulin receptors on their surface and use them to recognize antigens. When 
activated they differentiate into plasma cells and produce antibodies needed in the 
immune response. (Lebien and Tedder, 2008) 
The development of B cells takes place at several distinctive stages based on their antigen 
receptor status. B cell development starts already in the foetal liver where the 
hematopoietic stem cells are formed and then continues in the primary lymphoid tissue, 
the bone marrow, where these hematopoietic precursor cells differentiate into immature 
B cells. The early stages of the development comprise of the rearrangement of the 
immunoglobulin (Ig) genes called VDJ recombination. During VDJ recombination, the 
variable (V), diversity (D) and joining (J) segments of the immunoglobulin heavy chain 
(IgH) are rearranged and combined with the rearranged V and J segments of the 
immunoglobulin light chain (IgL). All in all, this can produce antibodies recognising up 
to 1013 different antigens. The first part of VDJ recombination, the joining of the heavy 
chain V, D and J segments, happens in the stage of development where the cells are called 
pro-B cells (Pieper et al., 2013). When these cells start to express a so-called pre-B cell 
receptor (BCR) where the heavy chain is already rearranged, but the light chain is still a 
surrogate light chain, the cells will become pre-B cells (Winkler and Mårtensson, 2018). 
In the pre-B cells, the immunoglobulin light chain segments will be joined and combined 
with the heavy chain. At this point the heavy chains are with type µ constant regions and 
cells expressing IgM molecules will be formed. These are called immature B cells (Pieper 
et al., 2013). Immature B cells will also start to express IgD on their surface and can then 
exit the bone marrow (Lebien and Tedder, 2008). These transitional B cells will then 
move into the spleen where they will finalise the early development by differentiating 




The early stages of B cell development are strongly regulated to avoid autoimmunity 
(Melchers, 2015; Pieper et al., 2013). There are four main checkpoints out of which three 
happen in the developmental stages in the bone marrow and the fourth one in the spleen. 
The first two checkpoints probe the functionality of the pre BCR (Melchers, 2015).  
The first checkpoint probes the heavy chain for successful rearrangement. The heavy 
chain is expressed on the cell surface together with a surrogate light chain to make sure 
that it can bind a light chain. This leads to the formation of the pre BCR. Before the 
development can go on, the newly formed pre BCR is checked for autoreactivity at the 
second checkpoint. Only the unreactive B cells will go on forming the pre-B cells. The 
third checkpoint probes for the functionality of the rearranged light chain. When a fitting 
rearranged light chain is combined with the heavy chain, a finalized BCR is formed. This 
checkpoint is also for the autoreactivity and B cells with highly autoreactive BCRs will 
undergo apoptosis while the B cells with no autoreactivity can continue development. As 
mentioned, the fourth checkpoint happens in the spleen at the transition to follicular and 
MZ B cells. Here the possible autoreactivity is screened for the last time before the 
maturation of the B cells. (Melchers, 2015) 
The marginal zone B cells in the spleen rapidly develop into plasma cells and start 
secreting IgM antibodies upon B cell activation by an antigen, thus forming the first-line 
defence against pathogens. In addition to this, the MZ B cells can undergo some class 
switch recombination (CSR) and produce type IgG and IgA antibodies as well. (Cerutti 
et al., 2013)  
Follicular B cells on the other hand normally circulate in the body and when activated by 
an antigen, they will start to proliferate and form germinal centres (GC) in the spleen and 
lymph nodes. In the GCs, the B cells undergo CSR and somatic hypermutation (SHM) in 
a process called affinity maturation. As a result of this the GC B cells will form memory 
B cells and long-lived plasma cells that have the ability to produce antibodies with high 
affinity to specific antigens. (Sagaert et al., 2007)  
The fifth checkpoint of B cell development takes place in the GC. The checkpoint makes 
sure that no autoreactive B cells are accidentally created in the process of SHM. Also, 
cells in which mutations have led to lower affinity antibodies will be discarded. 




Figure 1. Summary of the main points of B cell development. HSC = hematopoietic stem 
cell, SHM = somatic hypermutation, CSR= class switch recombination 
 
1.2 Somatic hypermutation 
Somatic hypermutation happens during affinity maturation of antigen activated B cells in 
germinal centres where point mutations are introduced into the V-regions of 
immunoglobulins. This is an important phase of the B cell development and makes it 
possible for the memory B cells and long-lived plasma cells to recognise specific antigens 
and form antibodies with high affinity to them. An important enzyme in the 
hypermutation process is activation induced cytidine deaminase (AID) that causes the 
mutations by deaminating deoxycytidine into deoxyuridine. (Di Noia and Neuberger, 
2007) 
Most commonly the mutations observed in SHM are substitutions, but some deletions and 
insertions are observed as well (Briney et al., 2012). The mutations have been observed 
to start roughly 150 bp downstream from the IgV promoter and most of the mutations are 
found within the three complementary determining regions (CDR) out of which the CDR3 
has the most diversity (Yeap et al., 2015; Neuberger and Milstein, 1995).  
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In general, somatic hypermutation process is thought to happen in two phases. In the first 
phase AID is recruited to the gene and DNA is deaminated. In the second phase the uracils 
added are removed and replaced by DNA repair mechanisms described later. (Kohler et 
al., 2012)  
It is not understood how somatic hypermutation is targeted to IgV regions (Odegard and 
Schatz, 2006). What is curious is that these hypermutations caused by AID can also be 
found in some other non-Ig genes in AID expressing B cells, but the number of mutations 
in Ig genes during the process of SHM can be up to 1000 times higher than in the non-Ig 
genes (Kohler et al., 2012; Buerstedde et al., 2014). This leads to a thought that there must 
be some mechanism that targets SHM especially to immunoglobulin genes, but it is still 
not fully known what leads to this targeting of SHM. However, there are theories, and 
one idea is that there are specific cis-acting elements and trans-acting factors that recruit 
AID and all the machinery needed to SHM to Ig loci (Odegard and Schatz, 2006).  
It has been proven that Ig enhancers play a role in determining the locus specificity of 
SHM and such sequences that are part of Ig enhancers or act like Ig enhancers in 
activating somatic hypermutation in neighbouring genes have been named diversification 
activators (DIVAC). Even though these DIVACs have been proven to activate SHM the 
exact mechanism by how they do it, is unknown. They do not increase the transcription 
of the mutated genes and it has been speculated that perhaps DIVACs promote the 
formation of a protein complex that guides AID to the transcription initiation complex of 
the mutated gene. Other plausible theories are that DIVAC bound factors recruit AID or 
that DIVACs induce changes in the elongation complex making DNA more accessible 
for AID. (Blagodatski et al., 2009; Buerstedde et al., 2014) 
Immunoglobulin enhancers have also helped in determining that the mechanism of 
activation of SHM must be evolutionally conserved because human Ig lambda and IgH 
enhancers can stimulate SHM also in chicken B cells even though normally chicken cells 
use gene conversion in increasing antibody affinity. (Buerstedde et al., 2014) 
 
1.3 Activation induced cytidine deaminase 
Activation induced cytidine deaminase is the initiating enzyme in the process of somatic 
hypermutation, as was already briefly described in the previous chapter. AID deaminates 
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deoxycytidine residues into deoxyuridine, which leads to mismatched U:G pairs in DNA 
during the G1 phase of the cell cycle. These pairs will then be recognized and repaired by 
the DNA repair machinery of the cell. (Di Noia and Neuberger, 2007; Feng et al., 2020; 
Pilzecker and Jacobs, 2019)  
AID is not only important in SHM but works also in other important processes in the 
germinal centre namely the class switch recombination and gene conversion (Feng et al., 
2020; Yeap et al., 2015). Gene conversion is another process that is used by some species 
to increase the affinity of antibodies and is related to SHM (Arakawa et al., 2002). The 
mechanism of action of AID in all the processes is the same (Yeap et al., 2015). In CSR, 
the mutations caused by AID just lead to double strand breaks and the change of the 
immunoglobulin type from IgM to either IgG, IgE, IgD or IgA (Feng et al., 2020; Qiao et 
al., 2017). Related to CSR, deficiencies in AID lead to an immunodeficiency called hyper-
IgM syndrome which is characterised by very low serum IgG, IgA and IgE and leads to 
increased susceptibility to infections (Revy et al., 2000). 
Some aspects characteristic for functioning of AID have been solved. AID belongs to the 
APOBEC cytidine deaminase family and is encoded by the AICDA gene (Buerstedde et 
al., 2014; Feng et al., 2020). It acts on single stranded DNA (ssDNA), but even though 
AID is known to require ssDNA for its function, it has been established that it binds rather 
structured than completely linear ssDNA (Qiao et al., 2017). Additionally, it has been 
solved that AID preferentially deaminates deoxycytidines within WRCY motifs where W 
= A/T, R = A/G and Y = C/T and therefore these are so called hotspots of AID (Feng et 
al., 2020; Qiao et al., 2017). The frequency of mutations caused by AID in the IgV-
regions is around 10-3 per base pair per generation which is million times higher than the 
rate of mutations in other genes of B-cell genome (Odegard and Schatz, 2006; Pilzecker 
and Jacobs, 2019). Also, the frequency by which AID targets the immunoglobulin switch 
(IgS) regions in CSR is the same than that of the IgV regions in SHM (Yeap et al., 2015). 
For the proper function of AID, its N- and C-terminal regions are important. The N-
terminus has a high net positive charge and carries the nuclear localisation signal which 
makes it possible that AID can work in the nucleus and mutate DNA. Then again, the C-
terminus contains a strong nuclear export signal and is especially essential for CSR as 
cells with mutations to AID C-terminus lose CSR activity but not SHM. On the contrary 
the opposite is noticeable with the N-terminal region as cells with mutations there lose 
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SHM activity but not CSR. Thus, it has been proposed that AID interacts with specific 
cofactors with these two domains, which lead the actions of AID to either somatic 
hypermutation or class switch recombination. (Muramatsu et al., 2004; Di Noia and 
Neuberger, 2007)  
Posttranslational phosphorylation of AID is also important. It is another factor that has 
been proposed to affect the choice of action of AID between SHM and CSR. It has been 
found out that AID is phosphorylated at serine 38, threonine 140 and tyrosine 184. Out 
of these, mutations at serine 38 decrease levels of CSR and SHM in the cells. Mutations 
at threonine 140 decrease significantly only SHM levels suggesting that it is a 
posttranslational modification specific for somatic hypermutation process. (McBride et 
al., 2008) 
As with the total targeting of SHM, it is not completely understood how AID is targeted 
to the IgV regions. As AID is known to require ssDNA for functioning, it is suggested 
that the high transcription levels of IgV genes could result in many locations with ssDNA 
substrates for AID and that could be one reason why AID is acting there. However, as the 
DIVACs introduced earlier do not function by increasing transcription but still increase 
AID induced mutations in SHM, there must be some other ways as well than simply 
increased transcription that work on targeting AID to specific areas. (Kohler et al., 2012; 
Buerstedde et al., 2014) 
 
1.4 DNA repair mechanisms in SHM 
In somatic hypermutation the DNA repair mechanisms that are normally required to work 
in a high-fidelity fashion work in a very error-prone way resulting in the transitions and 
transversions that are observed in the SHM process (Liu and Schatz, 2009). Both C-G 
and A-T base pairs are targeted, and Figure 2 summarises the repair pathways that lead 




Figure 2. The alternative DNA repair pathways used in somatic hypermutation and the 
types of mutations they lead to. AID = activation induced cytidine deaminase, UNG= 
uracil-DNA-glycosylase, MMR = mismatch repair, N = any base 
 
In total five alternative DNA repair pathways have been recognised to lead to the variety 
of mutations. First possible pathway is followed if the uracil is not processed by base 
excision repair (BER) or mismatch repair (MMR) and there will simply be transcription 
over the site. As U is similar to T, it instructs any known DNA polymerase to place an A 
into the opposite strand leading to a transition from the original C-G pair to T-A base pair. 
(Pilzecker and Jacobs, 2019)  
The second alternative depends on an enzyme called uracil-DNA-glycosylase (UNG) and 
can lead to both transversions and transitions. If the U is recognised and processed by 
BER, the enzyme UNG removes it creating an abasic site (Krijger et al., 2009). There are 
two splice variants of the Ung gene out of which UNG2, which is located in the nucleus, 
is more prominent in SHM (Nilsen et al., 1997). The abasic site gives no instructions on 
replication on the opposite strand, so both transversions and transitions can result here. 
Polymerases working to fix these lesions are called translesion synthesis (TLS) 
polymerases and one important TLS polymerase here is REV1 that can tolerate abasic 
sites (Pilzecker and Jacobs, 2019). REV1 is especially essential in creating G-C 
transversions to the site (Krijger et al., 2013).    
The U-G mismatch can also be recognised by the mismatch repair protein heterodimer 
MSH2/MSH6 which expands the mutations to the neighbouring base pairs. After 
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recognition of the mismatch, exonuclease EXO1 is activated, and it creates a single 
stranded DNA which will then be patched by DNA polymerase η (Pol η) (Pilzecker and 
Jacobs, 2019). Pol η is a very error-prone DNA polymerase and causes mutations at a 
frequency of 10-2. It mutates especially the A-T base pairs and thus expands the mutations 
to the neighbouring base pairs of the originally deaminated cytosine by AID (Zeng et al., 
2001; Wilson et al., 2005). Even though it seems that Pol η can work also independently, 
for most of the mutations at A-T base pairs the polymerase is activated and recruited to 
the lesion site by ubiquitinated DNA sliding clamp Proliferating Cell Nuclear Antigen 
(PCNA-Ub). PCNA-Ub is ubiquitinated at lysine residue 164, which is essential for its 
function (Krijger et al., 2011).  
The UNG2-dependent BER and MMR are not only competitive ways to process the added 
uracil, but they can work also together. It has even been estimated that about half of the 
G-C transversions in SHM are due to this hybrid pathway, which forms the fourth 
possibility for DNA repair in the process of SHM (Krijger et al., 2009; Pilzecker and 
Jacobs, 2019). However, the system how these transversions are created are not identical 
between the traditional UNG2 pathway and the UNG2 MMR hybrid pathway. The TLS 
polymerase REV1 is essential only when the transversions are created downstream of 
UNG2 processing alone. Then again when UNG2 and MSH2/MSH6 complex work 
together, the G-C transversions can be created also by action of other polymerases if 
REV1 is not available (Krijger et al., 2013). To support the idea of the hybrid pathway it 
has been established that the MMR machinery can interfere with ongoing BER when 
there are multiple lesion sites in the vicinity of each other (Schanz et al., 2009). It has also 
been speculated that G-C transversions within AID hotspots depend on UNG2 alone and 
outside of these hotspots on the hybrid pathway (Pilzecker and Jacobs, 2019). 
Furthermore, there is also the possibility that the U exists in the single stranded DNA 
created by EXO1 in MMR and then UNG2 proceeds in removing it as UNG2 is 1.7-fold 
more reactive on ssDNA when compared to double stranded DNA (Krijger et al., 2009; 
Pilzecker and Jacobs, 2019). 
Lastly, it has also been suggested that UNG2 alone can work together with PCNA-Ub 
and recruit Pol η to the lesion cite after removing the U and creating an abasic cite. This 
also expands the mutations to neighbouring A-T base pairs. (Krijger et al., 2009) 
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It is not completely known why these five alternative pathways work in an error-prone 
way instead of correctly repairing the lesions. However, there are some theories 
explaining why the DNA repair mechanisms work in these error-prone fashions during 
somatic hypermutation and make it possible for B cells to increase the affinity of the 
antibodies. One reason is in the ubiquitination of PCNA. It has been shown that when 
only mono-ubiquitinated, it recruits more error-prone DNA polymerases such as Pol η to 
the lesion site (Fan et al., 2020). Another theory is that some cis-acting elements that take 
part in targeting of somatic hypermutation itself also recruit machinery for error-prone 
repair to the Ig genes. However, at this point this has not been much studied as most of 
the studies have focused on identifying these cis-acting elements (Liu and Schatz, 2009; 
Odegard and Schatz, 2006). It is also thought that perhaps the N- and C-terminals of AID, 
that are important for its function, bind specific co-factors that help in recruiting error-
prone DNA repair machinery (Liu and Schatz, 2009). But as these are only some of the 
possible explanations, it is clear that the exact way how specifically error-prone 
polymerases are recruited to the somatic hypermutation site remains a mystery.  
 
1.5 G-quadruplexes 
As it has been mentioned, AID is known to preferentially bind structured ssDNA and one 
likely secondary DNA structure that AID could bind are the G-quadruplexes (G4) and the 
field studying these structures is rapidly evolving. (Feng et al., 2020; Qiao et al., 2017; 
Xu, Y. et al., 2020)  
So far, the basic structure of the G-quadruplexes has been solved. They are formed when 
four guanines interact via Hoogsteen hydrogen bonds and rearrange into co-planar G-
quartets (Figure 3). These quartets will then be stacked, and the stacks are stabilised by 
cations of which potassium (K+) is the most common one as shown in Figure 3 B and C 
(Sen and Gilbert, 1990). G4s are frequently found in Ig switch regions and telomeres and 
based on studying their sequences a basic G4 motif of G≥2NxG≥2NxG≥2NxG≥2 has been 
solved (Spiegel et al., 2020). This structure consists of stems with a minimum of two 
consecutive guanines. However, in mammals a stem length of three is more common and 
more stable. The loops in between the stems (denoted as Nx) can all be of various lengths 
although it was thought that shorter loops make more stable and faster folding G4s 
(Dhapola and Chowdhury, 2016; Kikin et al., 2006). However, recently also longer loop 
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lengths have been found, as well as discontinuations in the G-stems which lead to forming 
of bulges to the backbone of the G4 structure (Figure 3 C) (Spiegel et al., 2020). 
Furthermore, it has been proven that a long loop length in the middle of the G4 can 
actually stabilise the structure if it can form a double helix through complementary base 
pairing (Nguyen et al., 2020). 
 
 
Figure 3. A) Hoogsteen hydrogen bonding between guanines forming a co-planar G-
quartet. The central cation (coloured red) is binding to oxygen. B) An example of a 
possible G4 that can be formed. Central cations stabilizing the structure are shown. In 
this form the backbone runs parallel on each strand. C) An example of a possible G4 
structure showing a bulge on the backbone. Modified from Spiegel J, Adhikari S, 
Balasubramanian S. The structure and function of DNA G-quadruplexes. Trends in 
Chemistry. 2020;2(2):123-136. 
 
G-quadruplexes can be found in high numbers in different areas of the genome. 
Bioinformatic studies have found over 370 000 G4 prone sequences in the human genome 
(Bedrat et al., 2016). With high-throughput sequencing methods even more have been 
found, many which were not visible with only computational methods (Chambers et al., 
2015). It has also been possible to observe the actual formation of G4 DNA in the nuclei 
of live cells with fluorescence lifetime imaging microscopy (Summers et al., 2021). Many 
of the G4 structures in addition to IgS regions and telomeres are found in gene promoter 
and 5’ untranslated regions as well as at splicing sites. These are all functional areas in 
the genome pointing towards the idea that G4s have biologically essential regulating roles 
even though their actual function is still unknown (Summers et al., 2021; Chambers et al., 
2015). 
Additionally, it has been frequently observed that G-quadruplexes are connected to DNA 
damage (Hänsel-Hertsch et al., 2017). Furthermore, it has been established that G4s can 
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indeed induce DNA damage through a mechanism involving R-loop formation in cancer 
cells. R-loops are other noncanonical secondary DNA structures that are associated with 
genome instability. They form when the DNA duplex is opened and one of the strands 
forms an RNA:DNA hybrid by annealing to an RNA strand (De Magis et al., 2019). Some 
cancer tissues such as stomach and liver cancer tissues are also observed to have increased 
numbers of G4 structures when imaged with a G4 specific antibody BG4 (Biffi et al., 
2014). More-over, oncogenes in general are more G-rich than the rest of the genome 
supporting the fact that they have great potential to form G4s (Duquette et al., 2007). 
 
1.6 G-quadruplexes in AID mediated diversification 
As already stated, the Ig constant switch regions, where AID works during CSR, are rich 
in guanine and have the possibility to form many G4s (Dunnick et al., 1993). Formation 
of these G4s in switch region sequences following transcription has actually been proven 
in vitro and in vivo in Escherichia coli by electron and atomic force microscopies. In these 
experiments the G-rich sequences formed R-loops after unwinding of the DNA double 
helix during transcription. The formation of these loops was very efficient, one side of 
the loops composed of a formed G4 structure on the coding strand and the formed 
structures were stable (Duquette et al., 2004; Neaves et al., 2009). There is also evidence 
that these G4s within the IgS regions could be one of the nucleic acid secondary structures 
that AID binds during CSR rather than linear ssDNA (Qiao et al., 2017; Zheng et al., 
2015).  
It has been shown to be essential for functioning of AID during CSR, that it binds a 
bifurcated substrate. Folding of a sequence into a G4 structure could form such substrate. 
In one in vitro analysis, it seems that AID rather recognises a single-stranded overhang 
adjacent to the G4 structure instead of the core structure itself. In the same analysis, it 
was found out that AID more frequently mutates deoxycytidines close to G4 structures 
than deoxycytidines on a linear ssDNA composed of the same sequence. In fact, the 
binding affinity of AID to G4 was about 10 times higher than to a linear substrate with 
the same sequence. It also seems that AID homologues of the APOBEC family do not 
have this same preference for G4 and bifurcated substrates over linear substrates pointing 
towards the idea that G4s are important in AID specific processes. (Qiao et al., 2017) 
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Furthermore, in the scope of class switch recombination, it has been established that RNA 
molecules formed from the IgS regions can fold into G4 structures and guide AID to those 
areas. Especially the RNAs formed from the IgS coding strands were of importance as 
they are more G-rich (Zheng et al., 2015). Furthermore, if AID of mouse is mutated at 
glycine 133 so that it cannot bind these G4 structures formed in RNA, CSR is greatly 
reduced in mouse splenic B cells (Zheng et al., 2015). This same mutation has been also 
found in humans who have been diagnosed with hyper-IgM syndrome, a genetic Ig class 
switch deficiency (Mahdaviani et al., 2014). Recent in vivo evidence in mice shows that 
this same mutation in AID leads also to disruption of SHM in addition to CSR (Yewdell 
et al., 2020). The mutated form of AID is still catalytically active but cannot localise to 
the correct genomic regions and cannot bind synthetic G4-DNA in vitro (Yewdell et al., 
2020). In addition to mutating the G4 binding potential of AID, disrupting the formation 
of these G4s also seemed to reduce CSR (Zheng et al., 2015).  
In addition to switch regions, AID has been observed to localise with telomeric sequences 
in vitro  (Zheng et al., 2015) and as mentioned, telomeres are also known to be able to 
form many G4 structures (Spiegel et al., 2020). It even seems that the telomeric sequences 
can work as off-targets of AID and the DNA repair enzyme UNG protects B-cells from 
AID-mediated telomere damage (Cortizas et al., 2016; Safavi et al., 2020).  
Also, other off-targets of AID, such as oncogenes BCL and c-MYC, have been shown to 
form G4 structures within their promoter regions (Balasubramanian et al., 2011; Duquette 
et al., 2007). With c-MYC it has been actually shown in vitro that AID localizes to G4 
structures within its sequence. The G4 structures there are also formed following 
transcription and form similar loops that have been observed in switch regions (Duquette 
et al., 2005). G4s are also greatly associated with genome instability, and where G4s are 
formed, the normal Watson-Crick base pairing is impaired leaving one strand extendedly 
open so that AID could work there in addition to binding to the G4s. All this enforces the 
idea that G4s are associated with AID mediated diversification (Duquette et al., 2007; 
Spiegel et al., 2020; Qiao et al., 2017). 
This all raises a speculation that if G4s could be formed also within Ig variable genes, 
they could have an effect in targeting AID there during SHM. Although, traditionally it 
has been thought that the IgV regions do not form G4 structures as they are not G-rich 
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and therefore would not use similarly DNA secondary structures in recruiting AID during 
SHM (Pavri, 2017; Qiao et al., 2017). However, this has not been extensively studied. 
 
1.7 G-quadruplexes as possible drug targets 
As G-quadruplexes are frequently associated with malignancies and observed also in 
oncogene promoters, such as c-MYC, VEGF, BCL-2, PDGFA and TERT, there has been 
various studies regarding their potential on being new drug targets. In addition to G4s in 
oncogene promoters, G4s in telomeres have been extensively studied as targets for 
telomerase inhibition in cancer (Asamitsu et al., 2019; Balasubramanian et al., 2011). 
Indeed, many ligands binding G4 structures have been identified and they can have 
molecular structures varying for example from anthraquinones to perylenes and 
porphyrins (Figure 4) (Hurley et al., 2000; Mergny and Hélene, 1998).   
 
 
Figure 4. Possible G-quadruplex binding ligands as examples of varying molecular 
structures they can have. A) anthraquinones B) perylenes C) porphyrins. Modified from 
Hurley, L.H., R.T. Wheelhouse, D. Sun, S.M. Kerwin, M. Salazar, O.Y. Fedoroff, F.X. 
Han, H. Han, E. Izbicka, and D.D. Von Hoff. 2000. G-quadruplexes as targets for drug 
design. Pharmacology and Therapeutics. 85:141-158. doi: 10.1016/S0163-
7258(99)00068-6. 
 
The first evidence that G-quadruplex binding ligands can act as telomerase inhibitors 
comes already from 1990’s. The research was then done with an anthraquinone molecule 
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and has advanced the development of creating other G4 binding small molecules (Sun et 
al., 1997). The basis of functioning of these molecules is that they stabilise the G4 
structures in the telomeres hence inhibiting the normal functioning of telomerase, which 
eventually leads to shortening of telomeres and death of cancer cells (Mergny and Hélene, 
1998). They can also stabilise the G-rich 3´overhangs of telomeres in such form that 
telomerase cannot attach there anymore (Balasubramanian et al., 2011).  
One well known potent telomerase inhibitor is telomestatin which is derived from 
Streptomyces anulatus. It has a very similar structure to the actual planar G-quartet shown 
in Figure 3 A and it can interact with the G4 structure (Kim et al., 2002). With telomestatin 
there is in vitro and in vivo evidence in human acute myelomonocytic leukaemia cell line 
and mouse xenografts that it can reduce telomerase activity, induce telomere shortening 
and reduce tumour growth (Tauchi et al., 2006). Similar in vitro and in vivo effects to 
telomestatin have been observed with another G-quadruplex interacting molecule called 
BRACO-19 with the difference that BRACO-19 experiments were carried out to study 
uterus carcinoma (Burger et al., 2005).  
Stabilising the G4 structures in the promoter regions of proto-oncogenes generally leads 
to inhibition of expression of those genes. Therefore, many ligands for that purpose have 
also been studied (Asamitsu et al., 2019). Some of these small molecules could even be 
used specifically for one type of cancer. For instance, ligands targeting especially G4s at 
c-MYC, KRAS and BCL-2 over G4s at promoter regions of the other proto-oncogenes or 
telomeres have been developed (Hu et al., 2018; Lavrado et al., 2015; Amato et al., 2018). 
Similarly to telomestatin and BRACO-19, there is also in vitro and in vivo evidence of 
the effect of some of the small molecules targeting G4s at promoter regions (Kendrick et 
al., 2017). 
Despite the frequent studies of G4s as drug targets, none have reached clinical use. Many 
of the developed small molecules have had unfavourable pharmacological properties and 
even if some small molecules specific for certain proto-oncogenes have been found, 
specificity is often an issue (Asamitsu et al., 2019; Balasubramanian et al., 2011). 
However, still some G-quadruplex targeting molecules, such as quarfloxin which is a 
fluoroquinolone derivative, have made it to the clinical trial up to Phase II (Xu, H. et al., 
2017; Drygin et al., 2009). All in all, G-quadruplexes are a promising drug target and 
require more research in that field. 
15 
 
1.8 Clinical aspects 
Somatic hypermutation and understanding how it and AID are targeted to specific genes 
is very important in general as aberrant hypermutation is connected to the formation of 
cancer and B cell malignancies when they act in the wrong place. For instance, proto-
oncogenes such as BCL6, c-MYC and PIM1 have been found to be hypermutated by AID 
which has led to deregulated expression of these genes and B cell malignancies. As 
described, some of these oncogenes are also rich in guanine and it has been established 
that G-quadruplexes are formed within their promoters which strengthens the idea that 
G4s could be related to targeting of somatic hypermutation and AID. (Duquette et al., 
2007; Balasubramanian et al., 2011)  
In addition to hypermutations in oncogenes, many times also genomic translocations are 
observed in diseases such as Burkitt’s lymphoma, diffuse large B cell lymphoma and 
multiple myeloma. These translocations often include the immunoglobulin switch regions 
indicating that AID could be responsible for the lesions leading to these translocations. 
Moreover, to support this theory, AID has been shown to be responsible for a 
translocation between c-MYC and the IgH variable region in interleukin 6 transgenic 
mice. (Dorsett et al., 2007)  
 
1.9 Purpose of the study 
The aim of this project is to find out whether somatic hypermutation is targeted near G-
quadruplexes in a green fluorescent protein (GFP) reporter construct used and whether a 
strong G-quadruplex can also increase the mutation frequency. The previous findings in 
the group suggest that the distribution of the mutations in the process of somatic 
hypermutation does not correlate well with regions of ssDNA, but rather with the location 
of potential G-quadruplex forming sequences. The original hypothesis is that G4-
structures have an effect in targeting of somatic hypermutation when all the other 
requirements for mutation targeting are met. The goal is to test this hypothesis. 
The question that what makes SHM targeted to Ig genes is important and has been 
speculated for a long time, so this study also hopes to shed some light in it. This research 
also focuses more on the possible, less studied connection between SHM and G4s in 




Somatic hypermutation was studied with GFP loss assay where the decrease in green 
fluorescence represents mutations caused on green fluorescent protein gene in the somatic 
hypermutation process. The reporters designed and cloned specifically for this study were 
transfected into chicken DT40 bursal lymphoma B-cell lines where reporter was 
integrated in the genome so that somatic hypermutation was targeted on it. In addition to 
observing the change in green fluorescence from the cells caused by increasing numbers 
of mutations, the actual location, type and frequency of mutations were also studied by 
the means of sequencing the reporter constructs after B-cells had grown for one month.  
 
2.1 Analysis of G-quadruplexes with G4Hunter 
In the beginning the immunoglobulin variable regions and the GFP gene were studied for 
possible G-quadruplex forming sequences within them with an online software called 
G4Hunter (Brázda et al., 2019, http://bioinformatics.ibp.cz/#/). Multiple sequences 
coding for functional immunoglobulin heavy chain variable regions were studied and 
always one allele of few genes from every IGHV subgroup were included in the analysis 
(Table 1).  
Only two of the 28 analysed sequences could not form any G4 structures and most of 
them could form two or more. Positive G4Hunter score indicates that the quadruplex is 
found in the coding strand and a negative score indicates that it is found in the template 
strand. In total, 65 % of the quadruplexes found by this analysis are formed in the coding 
strand.  
 
Table 1. The G-quadruplex analysis of sequences coding for immunoglobulin heavy 
chain variable regions by G4Hunter. 
Gene Number of G-
quadruplexes 
found in the 
sequence 
Positions of the G-
quadruplexes 























IGHV1-46 1 305 1.2 





IGHV2-26 1 41 -1.2 









































































IGHV6-1 1 69 1.182 
IGHV7-4-1 1 223 1.286 
 
When the G4Hunter algorithm was validated, it was noted that the average G4Hunter 
score for known G4 forming sequences was 1.64 ± 0.46 but some G4 structures had also 
lower scores (Bedrat et al., 2016). 53 % of the G4 forming sequences found in this IGHV 
analysis scored propensity scores that fit in this previously defined average value. This 
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warrants further experimentation to find out if G4s are formed in IgH variable regions in 
vivo and whether they could play a role in SHM. 
After analysing the IGHV sequences and establishing that they have the possibility to 
form G4 structures, the GFP gene used as a reporter gene in this study was also analysed 
with G4Hunter. Based on previous studies of the group, it was already established that 
the GFP sequence can potentially form G4 structures so now the exact locations of G4 
forming sequences with the same settings used for analysing IGHV were found. In total, 
10 sequences were found likely to form G4s in the GFP coding gene and they have similar 
G4Hunter propensity scores to the G4 forming sequences found from the IgV regions. 
Most of the sequences overlap together to form 4 areas that are likely to form quadruplex 
structures (Table 2). All these areas were found in the template strand of the gene and 
Figure 5 visualises how they are positioned along the GFP gene. 
 








Sequence (coding strand) G4Hunter 
score  
1 159 CTGCCCGTGCCCTGGCCCACCCTCG -1.2 
2 168 CCCTGGCCCACCCTCGTGAC -1.2 
3 173 GCCCACCCTCGTGACCACCCTG -1.227 
4 178 CCCTCGTGACCACCCTGACC -1.2 
5 212 CTTCAGCCGCTACCCCGACC -1.2 
6 214 TCAGCCGCTACCCCGACCACA -1.143 
7 544 ACTACCAGCAGAACACCCCCATC -1.13 
8 558 ACCCCCATCGGCGACGGCCCCG -1.318 
9 616 CCGCCCTGAGCAAAGACCCCA -1.238 





Figure 5. The positions of possible G-quadruplex forming sequences in GFP gene. The 
G-quadruplex structures have been solved with G4Hunter online software. The red lines 
in the GFP denote the positions of mutations designed to diminish the G4 forming 




2.2 Different reporter constructs modelling somatic hypermutation with GFP loss 
For this study different reporter constructs based on green fluorescent protein for 
modelling somatic hypermutation were designed. The reporters were based on already 
existing GFP2 and GFP4 reporters described by Blagodatski et al. in 2009 and Buerstedde 
et al. in 2014 respectively. The basic reporters also included DIVAC sequences being 
DIVAC 2-3 in GFP2 reporter and a human Ig lambda enhancer core (Igλ) sequence in 
GFP4 (Figure 6). These acted also as positive controls in the study and are further referred 
as GFP2 2-3 and GFP4 Igλ reporters. Corresponding negative controls being the original 
ones described in the aforementioned papers contained no DIVAC sequences and are 
denoted only as GFP2 and GFP4 here. 
 
 
Figure 6. The reporters used as bases for the reporters cloned for this study. A) GFP2 2-
3 reporter, which works as a positive control. The negative control GFP2 is otherwise 
the exact same reporter construct but lacks the DIVAC 2-3. B) GFP4 Igλ reporter, which 
works as the other positive control. The negative control GFP4 is otherwise the exact 





For studying the effects of removing G4 structures from the reporter construct on 
targeting of somatic hypermutation, a so called GFP2 2-3 G4- reporter was cloned (Figure 
7). In that reporter, the possible G-quadruplex forming sequences analysed by G4Hunter 
(Table 2 and Figure 5) were modified so that their G4 forming potential was removed. 
Point mutations were introduced to the sequence at those points and the mutated sequence 
was again analysed with the G4Hunter to make sure that the G4 forming potential of the 
sequence was diminished with the designed mutations. In total 11 mutations were 
designed to make the required changes and after the changes the program could not give 
any G4Hunter scores to the GFP sequence anymore. These mutations and their exact 
positions are listed in Table 3. The locations of the mutations in relation to the identified 
possible G4 forming sequences are also shown in Figure 5. 
 
 
Figure 7. The GFP2 2-3 G4- reporter where possible G-quadruplex forming sequences 
are deleted. G4 = G-quadruplex. 
 
Table 3. The point mutations introduced to the GFP gene to remove the possible G4 
forming sequences 
Mutated amino acid 
(position as counted from 
the first amino acid of 
GFP) 
Original codon New codon 
Threonine (60) ACC ACA 
Threonine (63) ACC ACA 
Tyrosine (75) TAC TAT 
Proline (76) CCC CCT 
Tyrosine (183) TAC TAT 
Threonine (187) ACC ACA 
Proline (188) CCC CCT 







Proline (193) CCC CCT 
Aspartic acid (211) GAC GAT 
Proline (212) CCC CCT 
 
Also based on the GFP2 reporter, a tandem reporter with a combination of GFP and 
DsRed was cloned. Two versions of this so called GFP2+DsRed tandem reporter were 
created, GFP2+DsRed and GFP2+DsRed G4+, of which the latter contains a strong G4 
structure in between of the two fluorescent proteins (Figure 8). 
 
 
Figure 8. GFP2+DsRed tandem reporters. A) The basic tandem reporter with no 
modifications to G-quadruplex structures. B) The GFP2+DsRed G4+ tandem reporter 
with a strong G-quadruplex between the fluorescent proteins. G4 = G-quadruplex 
 
Additionally, to further study the effects of adding a strong G4 structure to the reporter 
on the targeting of somatic hypermutation, the same strong G4 structure as in the 
GFP2+DsRed G4+ reporter was added in the middle of the hypermutation targeting 
sequence (HTS) of GFP4 Igλ creating a so called GFP4 Igλ G4+ reporter (Figure 9). 
 
 
Figure 9. GFP4 Igλ G4+ reporter where a strong G-quadruplex structure is added in the 





To ensure the success of cloning these reporters, they were sequenced, and it was proven 
that they contain the desired changes. The complete reporters were then integrated into 
the genome of DT40 chicken bursal lymphoma B-cell lines. The GFP2 based reporters 
were integrated into a place where the IgL locus of the cells had been deleted and the 
GFP4 based reporters into a place where locus containing the gene for AID had been 
deleted. The reporters where then used to study the effects of G quadruplexes in targeting 
of somatic hypermutation on the green fluorescent protein in the settings of the GFP loss 
assay used.  
 
2.3 Removing the potential G quadruplex forming sequences of GFP gene 
decreases GFP loss significantly in GFP2 2-3 reporter 
The correctly targeted DT40 cells that had taken in the cloned GFP reporters were 
subcloned. The targeting efficacy varied for each reporter (Table 4) and always the best 
growing clones were chosen for subcloning. 14 days after subcloning, the cells were 
measured for their green fluorescence with fluorescence activated cell sorting (FACS).  
 
Table 4. Targeting efficacy of transfection of GFP2 reporters. 







GFP2  49 3 6 
GFP2 2-3 40 9 23 
GFP2 2-3 G4- 34 4 12 
 
The difference in GFP loss between GFP2 2-3 G4- and GFP2 2-3 reporters is statistically 
significant so that removing the potential G4 forming sequences of the GFP gene reduces 
the median GFP loss from 3.5 % to 1.8 % (p = 0.0096) (Figure 10). This suggests that 





Figure 10. Percentage GFP loss of GFP2 based reporters. All the subclones are plotted 
in the graph and the line represents the median. The actual value for median is shown 
above each reporter and the p-value is determined by Mann-Whitney test. 
 
In general, the percentage loss of green fluorescence in the GFP2 2-3 reporters was quite 
small even in the positive control as it has been observed in the previous studies that the 
GFP loss in the same reporter should be at least 4 % or more (Blagodatski et al., 2009; 
Kohler et al., 2012). Figure 11 shows one of the 12 subclones from each control and GFP2 
2-3 G4- reporter types measured by FACS. The figure represents the median of the 
subclones and also shows how the percentage of green fluorescent negative cells 
decreases when the G4 structures are removed and moves closer to the negative control, 
where almost no GFP loss is expected. 
 
 
Figure 11. Examples of GFP loss flow cytometry results from subclones of different GFP2 
reporters. A) negative control, B) positive control, C) GFP2 reporter where G4 structures 
have been deleted 
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2.4 Adding a strong G4 structure only slightly increases GFP loss in GFP4 Igλ 
reporters 
Like the GFP2 reporters, the correctly targeted DT40 cells containing the GFP4 reporters 
were subcloned. The targeting efficacy varied also for each GFP4 based reporter (Table 
5) and were generally worse than the targeting efficacy of the GFP2 reporters. This time 
12 days after subcloning, the cells were measured for their green fluorescence by FACS. 
 
Table 5. Targeting efficacy of transfection of GFP4 reporters. 







GFP4  63 9 14 
GFP4 Igλ 71 5 7 
GFP4 Igλ G4+ 54 2 4 
 
Unlike a clear statistically significant effect of removing G4 structures, adding one in the 
HTS sequence of the GFP4 Igλ reporter did not result in a statistically significant change 
in GFP loss after growing the subclones for 12 days. However, a slight increase from a 
median GFP loss of 12.9 in control to 14.9 in the reporter with an added G4 occurred 
(p=0.9682) (Figure 12). So, the amount of SHM happening was only slightly increased. 
 
 
Figure 12. Percentage GFP loss of GFP4 reporters. All the subclones are plotted in the 
graph and the line represents the median. The actual value for median is shown above 
each reporter and the p-value is determined by Mann-Whitney test. 
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In general, the intensity of fluorescence from GFP4 reporters is noticeably lower than that 
from GFP2 reporters and the GFP positive and negative populations are not as far apart 
from each other. Despite of that they were still well distinguishable and Figure 13 
representing the median GFP losses shows that the positive control here has already 
higher GFP loss than with GFP2 reporters. This goes well with previous studies denoting 
that the GFP4 assay is more sensitive than GFP2 assay and therefore resulted in bigger 
median GFP loss values (Buerstedde et al., 2014). 
 
 
Figure 13. Examples of GFP loss flow cytometry results from subclones of different GFP4 
reporters. A) negative control, B) positive control, C) GFP4 reporter where a strong G4 
has been added in the hypermutation targeting sequence. 
 
 
2.5 Adding a G4 in GFP2+DsRed tandem reporter decreases GFP loss 
Lastly, adding a strong G4 in the tandem reporter was also considered. The targeting 
efficacies of transfecting cells with these reporters were the highest of all (Table 6) and 
also here the best growing clones were chosen for subcloning. These tandem reporters 
were treated as the other GFP2 based reporters and measured at same timepoints.  
 
Table 6. Targeting efficacy of transfection of GFP2+DsRed tandem reporters. 







GFP2+DsRed 35 9 26 
GFP2+DsRed G4+ 25  11  44  
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Unlike adding a strong G4 in the GFP4 Igλ reporter, adding one in the tandem reporter 
did not increase GFP loss. Instead adding the quadruplex structure decreased the median 
GFP loss from 8.3 to 3.7 (p=0.0317) resulting in a statistically significant change (Figure 
14). There is no clear explanation why adding a G4 structure in the tandem reporter 
resulted in an opposite outcome than when adding a G4 in the GFP4 Igλ reporter.  
 
  
Figure 14. Percentage GFP loss of GFP2+DsRed tandem reporters. All the subclones 
are plotted in the graph and the line represents the median. The actual value for median 
is shown above each reporter and the p-value is determined by Mann-Whitney test. 
 
In general, the intensity of the green fluorescence coming from the cells containing the 
tandem reporters was between that of GFP2 2-3 and GFP4 Igλ reporters and Figure 15 
represents the median GFP loss observable. Here it also seems that adding the G4 





Figure 15. Examples of GFP loss flow cytometry results from subclones of GFP2+DsRed 
tandem reporters. A) Basic tandem reporter B) Tandem reporter with a strong G4 
between the two fluorescent proteins. 
 
As there was no control with only DsRed as a fluorescent protein, the flow cytometry 
results of loss of red fluorescence were not analysed due to lack of compensations 
possibilities. By studying the spectra of GFP and DsRed and taking into account the 
wavelengths used in the measurements, it was noted that there is some leakage of 
fluorescence from GFP to DsRed channel of the NovoCyte apparatus used for FACS and 
therefore cannot be analysed reliably. 
 
2.6 Sequencing gives more accurate information on how removing and adding of 
G4s affect the targeting of somatic hypermutation 
After subcloning the primary clones for GFP loss assay, they were further grown up to 
one month in total. The GFP loss at that point was again measured (Figure 16) and the 
GFP reporters were sequenced from the DT40 cell genomes. At the moment of extracting 
the genomic DNA from the cells, the GFP loss was markedly increased from the GFP 
loss of the subclones as expected as more time had elapsed. Cells containing the GFP2 2-
3 reporter were also measured for their fluorescence, but they were not sequenced as the 
reporter construct has been already sequenced (Tarsalainen and Alinikula, unpublished 
observations) and the existing data was used for comparing the results from GFP2 2-3 




Figure 16. GFP loss of primary clones right before sequencing to see how the 
accumulation of mutations had advanced from the subclone GFP loss analysis. A) 
GFP2 positive control, B) GFP2 reporter where G4 structures had been deleted, C) 
GFP2-DsRed tandem construct, D) GFP2-DsRed tandem construct with strong G4 
structure in between the genes of the two fluorescent proteins, E) GFP4 positive 
control, F) GFP4 where a strong G4 structure has been added in the hypermutation 
targeting sequence. 
 
As already seen from Figure 16, the situation at the moment of sequencing showed that 
there is less GFP loss in GFP2 2-3 G4- than in GFP2 2-3 reporter suggesting that there 
would be fewer mutations. Also, especially in the GFP4 Igλ reporters, adding a G4 has 
noticeably increased the GFP loss.   
From the sequenced reporters, the number and type of mutations were recorded, and the 
mutation frequency calculated (Table 7). The sequencing results fit together with the 
FACS results as the mutation frequency is lower in GFP2 2-3 G4- reporter when 
compared to GFP2 2-3 reporter and again higher in GFP4 Igλ G4+ reporter when 
compared to GFP4 Igλ reporter. Also, in the tandem reporter, adding a G4 has slightly 
increased the mutation frequency.  
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Table 7. The number, frequency and types of mutations found in the reporters after one 
month of growing. GFP2 2-3 had been sequenced already before and that data was 
















94 56 53 52 39 48 
Number of bp 
sequenced 
70876 42224 55438 56108 38844 49392 
Number of 
mutations 
53 25 61 80 135 288 
Mutation 
frequency 
0,000748 0,000592 0,0011 0,001426 0,003475 0,005831 
Mutations/ 
1000 bp 
0,747785 0,59208 1,100328 1,425822 3,47544 5,830904 
Transitions 18 5 21 17 118 267 
Transversions 31 10 25 28 10 13 
Insertions 4 18 6 23 19 27 
Deletions 0 8 9 12 13 6 
Mutations/ 
seq 
0,56383 0,446429 1,150943 1,538462 3,461538 6 
 
Furthermore, the mutations were positioned along the GFP constructs with transcription 
start site (TSS) as starting point. For the Figures 17-19 the number of mutations has been 
divided into 50 base pair bins and normalized to the number of sequences obtained for 
analysis. The figures clearly point out the differences in the mutation distributions along 
the different reporters. 
 
 
Figure 17. The distribution of mutations in A) GFP2 2-3 and B) GFP2 2-3 G4- reporters. 
The positions from where the G4 structures were deleted in GFP2 2-3 G4- reporter are 




Figure 18. The distribution of mutations in A) GFP2+DsRed and B) GFP2+DsRed G4+ 
reporters. The position of the added strong G4 structure in the second reporter is marked 




Figure 19. The distribution of mutations in A) GFP4 Igλ and B) GFP4 Igλ G4+ reporters. 
The position of the added G4 is marked with red in the second reporter. TSS = 
transcription start site, G4 = G-quadruplex, HTS = hypermutation targeting sequence 
 
As seen from Figure 17 the most common mutation sites in GFP2 2-3 are located close 
to the points where the possible G4 forming sequences were. However, the distribution 
of the mutations has clearly shifted in the GFP2 G4- reporter and it seems that removing 
the G4s has not only decreased the mutation frequency, but it has also clearly reduced the 
number of mutations especially at those points where the G4s used to be. 
Figure 18 moves on showing the effects of adding a strong G4 to the distribution of the 
mutations along the reporters. Here it also seems that adding a G4 has not only an effect 
in increasing the mutation frequency, but it also “attracts” mutations. This is seen as a 
peak in number of mutations around the G4 structure in GFP2+DsRed G4+ reporter in 
comparison to the same location from TSS in GFP2+DsRed reporter. 
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The GFP4 reporters in Figure 19 continue showing the effects of adding a strong G4 
structure to the locations of the mutations. Here a similar effect is observable as in Figure 
18 with GFP2+DsRed tandem reporters. A slight shift in the mutation distribution 
towards the G4 structure is seen in GFP4 Igλ G4+ reporter when compared to the same 
area in GFP4 Igλ reporter. 
 
2.7 Studying the strand bias of mutations in GFP4 reporters 
The GFP4 based reporters were integrated into the genome of DT40 cells that were devoid 
of the UNG enzyme. In UNG deficient cells, most of the mutations are G to A and C to 
T transitions as the mutations site is mainly repaired by transcription over the site. 
(Saribasak et al., 2006) Therefore, they can be used to assess the strand of origin of the 
formed mutations. 
This is also well represented in this analysis as around 80 % of all the mutations observed 
are transitions (Table 7). The reporters were sequenced only in the direction of the coding 
strand and it can be deducted that if the observed mutation was G to A, the original 
mutation was in the template strand and if C to T, the mutation in the coding strand. As 
seen in Table 8, the percentage of G to A transitions slightly increases from 43 to 51 % 
(p=0.7548) in the GFP4 Igλ G4+ reporter when compared to the reporter without strong 
G4 structure. However, this is not statistically significant and there is close to no 
difference in the portion of C to T transitions. The biggest change is observable in the 
amount of insertions and deletions, but from there, there is no reliable evidence that on 
which strand the original mutation has occurred. 
 













GFP4 Igλ 43.0 35.6 4.4 8.1 8.1 
GFP4 Igλ 
G4+ 







The results of this study suggest that G-quadruplexes have an effect in targeting of 
somatic hypermutation. Removing the possible G4 structures in the used GFP reporters 
significantly reduced GFP loss as well as mutation frequency and there were fewer 
mutations at the positions from where the G4s had been removed. Adding a strong G4 
did not lead to a statistically significant increase in GFP loss, but still increased the 
mutation frequency and caused an increase in the number of mutations around the position 
where the G4 was added when compared to the same position in the control reporter. This 
goes well together with the previous observations in CSR that AID preferably binds and 
mutates cytosines close to G4 structures (Qiao et al., 2017). Previous observations in mice 
and with mouse B cells also suggested that mutating AID so that it cannot bind G4s, 
diminishes CSR and SHM (Yewdell et al., 2020; Zheng et al., 2015). CSR was also 
diminished if the folding of the G4 structures was disrupted (Zheng et al., 2015). In light 
of this experiment, it also seems that removing the G4 structures from the target gene also 
decreases SHM without mutations in AID. 
As the median GFP loss of the measured GFP4 Igλ G4+ subclones was slightly increased, 
it raises a question whether increasing the sample size from 12 could have resulted in a 
statistically significant result if the difference in GFP loss had persisted. Also, as the 
mutation frequency in the GFP4 Igλ G4+ is almost twice as much as in GFP4 Igλ reporter 
it lets us expect that there should have been more GFP loss observed already with this 
sample size. It can be speculated that the reason for the statistically unsignificant change 
in GFP loss could lie also in the possibility that the mutations happening in GFP4 Igλ 
G4+ have not led to stop codons as often or have changed the codon into another one that 
still codes for the same amino acid as the original one and thus do not change the amino 
acid sequence of GFP.  
What causes the decrease in GFP loss when a strong G4 structure is added to the 
GFP2+DsRed tandem reporter is not known. Perhaps also for this reporter the study could 
be repeated with a larger sample size. However, also in this reporter the mutation 
frequency was increased, and the locations of mutation shifted towards the G4 structure. 
Therefore, it seems that the effects of adding a G4 could be more in increasing the 
mutations then decreasing them even though the GFP loss was reduced in this case. 
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Another interesting aspect that comes to the G-quadruplex structures removed in this 
study from the GFP2 2-3 reporter is that they are at this point only theoretical G4 
structures as the sequences forming them have been predicted by an online software but 
have not been actually observed to form the quadruplex structure in GFP gene. On the 
contrary, the strong G4 structure used has been studied before and is known to form a 
very stable G-quadruplex  (Nguyen et al., 2020).  
The effects of the strong G4 were noted also in the transcription of GFP as the 
transcription of the fluorescent protein was always lower in the reporter containing the 
quadruplex structure when compared to the same report without it. This suggests that the 
DNA secondary structure really is there as it is known that it can hinder the functioning 
of RNA polymerase and hence lead to lower transcription  (Nayun Kim, 2019; Broxson 
et al., 2011; Duquette et al., 2004).  
On the other hand, removing the G4 forming potential of the GFP gene did not affect 
transcription and the transcription levels of GFP in GFP2 2-3 G4- reporter remained the 
same compared to GFP2 2-3 reporter. As adding a G4 structure decreases transcription, 
it could have been assumed that removing them would respectively increase it by 
removing hinderance from transcription. This leads to the question that could the decrease 
in GFP loss and mutation frequency and the change in mutation distribution be a result of 
something else than removing actual G4 structures. However, important to note here as 
well is that the possible removed G4s were in the template strand and the G4 was added 
to the coding strand. The articles that have discussed the effects of G4s in transcription 
have described G-quadruplexes especially in the coding strand (Nayun Kim, 2019; 
Broxson et al., 2011; Duquette et al., 2004) and therefore it cannot be expected that G4s 
in template strand would work in the same way and have a similar effect in transcription. 
As disclosed before, WRCY hotspots where W = A/T, R = A/G and Y = C/T have been 
recognized to be the preferable locations for mutations caused by AID  (Feng et al., 2020; 
Qiao et al., 2017). These hotspots were not taken into account when designing the 
mutations in GFP gene to remove the G4 forming potential of the gene. By afterwards 
analysis of the changed bases in GFP gene together with the hotspots, it was noted that 2 
out of the 11 mutations created when cloning the GFP2 2-3 G4- reporter changed such 
hotspots from TACC to TATC. In theory this could affect at least to some extent the 
number of mutations close to those hotspots. However, these were only two hotspots 
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disrupted from the many that can be found from GFP gene. Additionally, in a previous 
study from Qiao et al. in 2017, it has been established that in CSR, the G4 structure could 
possibly even override the hotspot preference of AID so perhaps the same could apply 
here in SHM. Therefore, disruption of these two hotspots is most likely not the only 
reason for the significant change observed.  
What is also many times discussed when it comes to the mutations in somatic 
hypermutations process, is the strand bias of the mutations. It is known that both DNA 
strands, the coding and the template strand, are targeted by AID and some bias over 
deaminated cytosines in the coding strand over the template strand has been observed 
(Sohail et al., 2003; Saribasak et al., 2011). As the GFP4 reporters where transfected into 
cells deficient of UNG2, most of the mutations were only G to A and C to T transitions 
as the repair of the uracil in the DNA was mainly conducted by replication over the lesion 
site (Saribasak et al., 2006).  
As seen from Table 8 there is a slight increase in G to A transitions in the GFP4 Igλ G4+ 
reporter when compared to the GFP4 Igλ. So, a slight increase in the mutations happened 
in the template strand when the G4 structure was added to the coding strand. However, 
this increase was not statistically significant and the portion of mutations in the coding 
strand itself did not decrease and the change was mainly dependent in the decrease of 
insertions and deletions that happened less in the GFP4 Igλ G4+ than in the GFP4 Igλ 
reporter. Of the deletions and insertions, it is still difficult to say on which strand the 
original mutation had been. From the deletions it can be always speculated that if the 
deleted base from the coding strand is C, most likely it could be the C that was originally 
deaminated. However, this would not change the numbers drastically and the result would 
still be inconclusive.  
From the GFP2 reporters it is difficult to say that on which strand the mutations have 
originally happened as the DNA repair machinery in them is intact and all the possible 
mutations with any method described in SHM (Figure 2) can occur. Also, the results even 
from the GFP4 Igλ reporter are not in line with the previously obtained data in other 
studies where more mutations happen in the coding strand (Sohail et al., 2003; Saribasak 
et al., 2011). Also, the results from Qiao et al. suggest that the ideal deamination site for 
AID would be at the third position from a guanine stem in G4, but still on the same strand 
with the structure and the results here oppose this observation as well. However, the 
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difference between the percentage of mutations on each strand is small and the sample 
size very limited so a larger analysis with perhaps more high-throughput sequencing 
could be helpful in getting clearer results. Therefore, in the scope of this thesis work a 
clear statement on the effect of G4s on the strand bias cannot be given.   
Also, for future studies it would be interesting to test if adding two or more strong G4 
structures could result in a stronger effect in the number and locations of mutations. In 
GFP2 2-3 G4- reporter, there are several possible G4 structures close to each other that 
are disrupted, and the results of that reporter compared to the control are more significant. 
Therefore, maybe adding two G-quadruplexes next to each other would also result in 
more GFP loss in GFP4 Igλ G4+ reporter.  
One big question still remaining is that are these findings done within the GFP gene 
actually relevant in the immunoglobulin variable genes in B cells. As pointed out in the 
introduction, it is well known that the switch regions can form G-quadruplexes but 
evidence from the variable regions remains sparse (Dunnick et al., 1993; Pavri, 2017; 
Qiao et al., 2017). However, when studying some of the human IgV regions with the 
G4Hunter program in this study, it seems that the sequences have a potential to form G4s 
as well (Table 1) even though they have not been extensively studied. This suggests that 
the role of G4s in AID mediated diversification could extent from the more studied CSR 
to SHM as well. Still to validate this in the future, it would be interesting to see if the G4s 
within IgV regions could be imaged similarly with electron and atomic force 
microscopies like within the switch regions (Neaves et al., 2009; Duquette et al., 2004). 
An interesting idea is also that if G-quadruplexes do not have an important role in 
targeting of somatic hypermutation to the IgV areas, maybe their relevance is in the off 
targeting of somatic hypermutation as it is known that oncogenes are rich in their guanine 
content, their promoters are observed to form G4s and G4 structures are observed in 
cancerous tissue (Balasubramanian et al., 2011; Biffi et al., 2014). 
As a conclusion, this thesis suggests that G-quadruplexes can play a role in determining 
the exact locations of mutations when other requirements for targeting of somatic 
hypermutation are met. Even though the G4s seem to have an effect, they most likely 
cannot override the other targeting mechanisms. Meaning that there still must be 
transcription going on and stalling of polymerase so that there are ssDNA substrates 
available for AID and mutation enhancers such as DIVACs are needed to possibly recruit 
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all the machinery needed for SHM. Also, the exact mechanism how G4s work in targeting 
of the mutations is still unknown. Perhaps they can stabilise the single-strandedness of 
the opposite DNA strand so that AID can more easily target deoxycytidines in it, or it can 
form a good, bifurcated structure for AID to bind and mutate deoxycytidines around it. 
The G4s also lowered GFP transcription and can therefore possibly contribute to 
polymerase stalling, but with the limited data from this study, it is impossible to provide 
a detailed description of the actual mechanism. So, there is still a lot of work to do for the 
future. Additionally, the exact role of G4s in the targeting of SHM to IgV regions when 
compared to their role in the off targeting of SHM requires more looking into. 
 
 
4. Materials and methods 
4.1 Analysing the G-quadruplex structures in immunoglobulin variable genes  
The sequences coding for immunoglobulin heavy chain variable regions were studied 
with an online program called G4Hunter (version 3.3.3-3-g32cee6f, 
http://bioinformatics.ibp.cz/#/). It is an available to all platform that can be used to 
analyse possible G4s formed by sequences. The parameters for the search, the window 
and the threshold, were chosen to be 20 and 1.2 respectively (Bedrat et al., 2016; Brázda 
et al., 2019). The sequences for the IgV regions were obtained from the IMGT Database 
(Giudicelli et al., 2005). In total 28 sequences were analysed comprising of few functional 
sequences from each IGHV subgroup (Table 9). 
 
Table 9. The genes for immunoglobulin variable regions used for G-quadruplex 
analysis and IMGT accession numbers for them. 

































4.2 Designing the GFP reporters used 
The reporters that were designed for this study were based on already existing GFP2 and 
GFP4 reporters described in articles by Blagodatski et al. in 2009 and Buerstedde et al. 
in 2014 respectively (Figure 6). The original GFP reporters will serve as negative 
controls. 
The GFP2 reporter includes a DIVAC sequence called DIVAC 2-3 and will be therefore 
called GFP2 2-3. The DIVAC 2-3 is a part of the chicken immunoglobulin lambda 
enhancer sequence and is known to lead to high levels of GFP loss (Kohler et al., 2012). 
39 
 
In the reporter it is inserted immediately downstream of the polyA-site sequence of the 
GFP -ires-Bsr-transcription unit. Additionally, mouse R1 intronic sequence is added right 
upstream of the Rous sarcoma virus promoter included in the basic reporter (Alinikula et 
al., Manuscript).    
The GFP4 reporter includes a DIVAC sequence called Igλ and is therefore referred to as 
GFP4 Igλ reporter. The Igλ is the human immunoglobulin lambda enhancer sequence 
which has been shown to act as a diversification activator in GFP4 reporter assay 
(Buerstedde et al., 2014). The Igλ has been inserted into the reporter downstream of the 
GFP gene at BamHI restriction cite. 
 
4.2.1 GFP2 2-3 G4- reporter 
This reporter was used for studying how removing G4s from GFP coding sequence affects 
the targeting of somatic hypermutation on it.  
For studying the G4 structures formed naturally by GFP gene, the same G4Hunter online 
program was used as for analysing the G4 structures in IgV genes. The parameters for 
analysis were also the same. Mutations were designed to those sequences with the help 
of SnapGene (version 3.3.4) so that they could not form G4 structures anymore. 
 
4.2.2 GFP2+DsRed reporter 
Gene for DsRed from another vector (pX458-DsRed, Addgene) was taken and inserted 
into GFP2 2-3 reporter construct after the GFP coding sequence with only a sequence for 
a T2A self-cleaving peptide between them. 
 
4.2.3 GFP2+DsRed G4+ reporter 
The GFP2+DsRed reporter was further modified by adding a strong G4 structure directly 
after GFP gene before the T2A sequence. The sequence for G-quadruplex used here has 
been studied before by Nguyen et al. in 2020. It has a sequence 5´-
TTGGGTGGGTTTCGCGCAGCGTTTGGGTGGGTT-3´, and it was added to the 
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coding strand. It is known to quickly form a stable G4 structure with a duplex stem-loop  
(Nguyen et al., 2020). 
 
4.2.4 GFP4 G4+ reporter 
This reporter is based on a GFP4 reporter. There preceding the GFP coding sequence is a 
hypermutation targeting sequence and in this study, the strong G4 was created in the 
middle of this HTS, on the coding strand, after tryptophan 32. The sequence used for G4 
is the same as in GFP2+DsRed G4+ reporter. 
 
4.3 Cloning the GFP reporters 
The designed GFP reporters were cloned with a process called In-Fusion Cloning. The 
pieces of the reporters for the cloning process were created by polymerase chain reactions 
(PCR). 
 
4.2.1 Polymerase chain reaction 
The primers for the PCR phase were designed with the help of SnapGene (version 3.3.4) 
so that the desired mutations or the beginning/end of the desired insert are contained at 
the 5’ end of the primer. Full list of used primers is found in Appendix 1.  
All PCR reactions were carried out with the Q5® High-Fidelity DNA Polymerase from 
New England Biolabs (NEB) and the recommended reaction setup given in the official 
protocol for this enzyme by NEB was used (see Appendix 2 for the setups used). For 
longer PCR reactions (PCR product > 13 000 bp) the amount of template used was 500 
pg-5 ng and for smaller inserts (PCR product 50-800 bp) it was 100 pg.   
After the PCR, the samples were run on an agarose gel. 2.5 % agarose was used for small 
DNA fragments and 0.6 % for long. The desired bands were then cut out from the gel and 
the DNA was extracted and purified with NucleoSpin Gel and PCR clean-up mini kit 





4.3.2 In-Fusion reactions 
To combine all the parts of the reporter constructs created by PCR, In-Fusion reactions 
were carried out. The In-Fusion® HD Cloning Kit from Takara Bio was used and the 
manual given by them was followed for optimal reactions.  
 
4.3.3 Miniprep 
To produce the plasmids containing the GFP reporters created by In-Fusion reactions, the 
plasmids were transformed into Stellar™ Competent Cells (Clontech Laboratories, Inc. 
Takara Bio Company). For each transformation, 30 µl of competent cells in a 1.5 ml 
Eppendorf tube were used and always 2.5 µl of In-Fusion reaction was added on them. 
The mixtures were incubated for 30 minutes on ice, heat shocked for exactly 60 seconds 
at 42 °C and incubated for further 2 minutes on ice. The volume of the cell suspension 
was increased to 500 µl with SOC-medium that was pre-warmed to 37 °C and incubated 
for one hour at 37 °C by shaking at 225 rpm. An appropriate amount of the suspension 
was then plated on agar plates containing ampicillin (100 µg/ml). The plates were let to 
incubate at 37 °C overnight and afterwards in room temperature for 6 hours. Well grown 
bacterial colonies were chosen and suspended in 3 ml LB-medium containing ampicillin 
(100 µg/ml). This bacterial culture was then grown overnight at 37 °C. 
The plasmids were then purified from the bacteria with GeneJET Plasmid Miniprep Kit 
(#K0503) from ThermoFisher Scientific. The purification was carried out as instructed 
by the manufacturer of the kit. 
To ensure that the plasmids produced and purified were correct and contained the desired 
changes, samples from them were prepared for sequencing with Mix2Seq Overnight kit 
(Eurofins Genomics) and sent to Eurofins in Germany where the sequencing took place. 
After receiving the results, the sequenced sections were aligned with the desired plasmid 
with the help of SnapGene (version 3.3.4) to see which minipreps contained the correct 





To produce needed amounts of plasmids containing the reporter constructs for 
transfection, maxipreps were made from the minipreps proven correct by sequencing.  
Roughly 3 ng of plasmid DNA and 25 µl of Stellar Competent Cells were used for each 
transformation. The cells and DNA were mixed in an Eppendorf tube and incubated 30 
min on ice. Next the cells were heat shocked for 60 seconds at 42 °C and incubated for 
further 2 minutes on ice. The volume of the cell suspension was increased to 500 µl with 
SOC-medium pre-warmed to 37 °C and incubated for an hour at 37 °C by shaking at 225 
rpm. After the hour, an appropriate amount of this cell suspension was plated on an agar 
plate containing ampicillin (100 µg/ml). The plates were let to grow overnight at 37 °C.  
From every plate one bacterial colony was chosen and transferred into 2 ml LB-medium 
containing ampicillin (100 µg/ml) and this pre-culture was incubated for 7 hours at 37 °C 
by shaking at 225 rpm. 1 ml of this pre-culture was then transferred to 150 ml fresh LB-
medium with ampicillin (100 µg/ml) and returned to 37 °C and incubated overnight by 
shaking at 225 rpm.  
The plasmids were then purified with GenElute™ HP Endotoxin-Free Plasmid Maxiprep 
Kit from Sigma-Aldrich (Catalogue number NA0410) by following the official 
instructions. 
Complete maps of the final plasmids can be found from Appendix 3. 
 
4.4 GFP loss assay 
4.4.1 Linearization and precipitation of the reporter plasmids  
To prepare the DNA needed for transfection, the plasmids containing the reporter 
constructs were linearized with NotI restriction enzyme. Always 50 ng of the plasmid 
DNA was linearized for one transfection. 2 µl of restriction enzyme was used per 
digestion reaction and the reaction was let to process overnight at 37 °C.  
On the next day, 1 µl of the linearized plasmid was run on a 1 % agarose gel to ensure a 
complete linearization. When the result was satisfactory, the linearized plasmid DNA was 




The precipitation was started by adding 500 µl of ice cold 100 % EtOH on the DNA. The 
mixture was vortexed well and the precipitate was centrifuged down with a speed of 
15 000 g for 5 minutes. The supernatant was removed, 500 µl of cold 70 % EtOH was 
added on the pellet and the centrifugation was repeated for three minutes. The supernatant 
was again carefully completely removed, and the pellet was air dried at room temperature 
for about 10 minutes until it was completely dry.  
The dried pellet was eluted in 50 µl TE-buffer and the volume was increased to 300 µl 
with PBS. 
 
4.4.2 Cell culture and transfection 
Two cell lines were used in the experiments, namely DT40 pseudoV–IgL–/PuroAIDR2 
(Blagodatski et al., 2009) and DT40 UNG−/−AIDR/Puro (Buerstedde et al., 2014). They are 
both chicken DT40 bursal lymphoma cell lines and are grown at 40 °C with 5 % CO2 in 
medium consisting of RPMI-1640 with 10 % FBS, 1 % NCS, 1 % penicillin-streptomycin 
(10 000 U/ml) 1 % Glutamax (Gibco) and 0.1 % β-mercaptoethanol (DT40-medium). The 
cells were grown till the cell viability was 90 % or higher and density of viable cells was 
between 0.5 and 0.9 million cells per millilitre. The reporters based on GFP2 were 
transfected into DT40 pseudoV–IgL–/PuroAIDR2 cell line and those based on GFP4 into 
DT40 UNG−/−AIDR/Puro cell line. 
12 million cells were harvested for one transfection by centrifugation at 200 g for 5 
minutes. The correct number of cells was resuspended in 400 µl PBS and transferred into 
a pre-chilled 0.4 cm cuvette. 300 µl of plasmid DNA containing 50 µg of DNA was added 
on the cells in the cuvette and incubated for 10 minutes on ice. The cells were 
electroporated with MicroPulser™ Electroporation Apparatus (Bio-Rad) with a voltage 
of 0.7 kV, resistance of the circuit 200 Ω and the capacitance of the apparatus being 25 
µF. After electroporation, the cells were moved back on ice for five minutes and then 
transferred into 10 ml of pre-warmed DT40 medium. The cells were divided on a 96-well 
plate so that each well contained 100 µl of the transfected cells.   
The cells were grown overnight at 40 °C and on the next day, blasticidin selection was 
added on the cells to make sure that only the cells that have taken in the plasmid are 
growing. For the blasticidin selection, 100 µl of medium containing 30 µg/µl blasticidin 
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was added on each well with the transfected cells. Here the medium used was conditioned 
medium with a consistency of 40 % old media harvested from growing cells, 5 % FBS 
and 55 % fresh DT40-medium. After the selection, the cells were let to grow at 40 °C for 
9 days. 
To prepare the conditioned medium, the old medium was harvested from the growing 
cells by centrifugation at 500 g for 5 minutes so that all the cells were pelleted to the 
bottom. The medium was collected and filtered through a 0.2/0.22 µm filter and was then 
ready to use. 
On days 7-9 after transfection, the primary clones were picked from the wells and 
transferred to clean wells on a new 96-well plate containing 200 µl of freshly made 
conditioned medium consisting of 25 % old medium harvested from growing cells, 70 % 
fresh DT40 medium and 5 % FBS. On the next day, 100 µl of the cells were moved into 
a neighbouring empty well and replaced with 100 µl of fresh medium on the original 
wells. Into the new wells 100 µl of medium with puromycin (2 µg/ml) was added. The 
plates were placed back at 40 °C over night. 
The results of the puromycin selection were studied on the next day, when correctly 
targeted cells died in the wells containing puromycin. The correctly targeted clones were 
then moved into bigger volume and split every 1 to 2 days according to their growth. 
When the viability of the cells was over 90 %, part of them were saved by freezing and 
storing them in liquid nitrogen and part were further subcloned. For subcloning, 96-well 
plates with 300, 600 and 900 cells were created and let to grow for 7-8 days at 40 °C. 
After this time, 12 clones were picked and transferred into 200 µl of fresh DT40-medium 
and let to grow. 
 
4.4.3 Flow cytometry 
For DT40 pseudoV–IgL–/PuroAIDR2 cells containing the GFP2 reporters, 14 days after 
subcloning the 12 subclones picked were studied with flow cytometry for their degree of 




For the fluorescence activated cell sorting (FACS) NovoCyte Flow Cytometer was used. 
The laser used was 488 nm, filter for GFP 530/30 and for DsRed 585/40 and always 
50 000 live cells were recorded. 
Appropriate gates were adjusted for each subclone measured. 
 
4.5 Sequencing of the fluorescent proteins  
For sequencing, the primary clones subcloned for GFP loss assay were further grown up 
to four weeks. Then the genomic DNA was extracted from the cells with Quick-DNA™ 
Miniprep Kit from Zymo Research (Catalogue number D3024). 3-5 x 106 cells per each 
clone were used for the gDNA extraction and the protocol for cell suspensions given by 
the manufacturer was followed.  
From the extracted gDNA, the reporter sequences were amplified by PCR. Always 400 
ng of DNA was used as a template and like when cloning the reporters, all PCR reactions 
were carried out with the Q5® High-Fidelity DNA Polymerase and the recommended 
reaction setup was used (Appendix 2). To ensure correct PCR products, 3 µl of each 
product was run on a 1.5 % agarose gel with 120 V for 1 hour and 15 minutes.  
The correct PCR products where then cloned into pCR™4Blunt-TOPO® plasmid vectors 
(Zero Blunt® TOPO® PCR Cloning Kit for Sequencing from Invitrogen, catalogue 
number 450159). For each reaction 2 µl of PCR product was used and the reaction was 
set up according to instructions given in the official protocol of the kit. The incubation 
time of the reaction was increased from 5 minutes to 20 before transforming the clones 
into Stellar™ Competent Cells.   
For the transformation 2 µl of TOPO® Cloning reaction and 40 µl competent cells were 
used. The transformation reactions were incubated for 30 minutes on ice, heat shocked 
for exactly 60 seconds at 42 °C and incubated for further 2 minutes on ice. Then the 
volume of the cell suspension was increased to 500 µl with SOC-medium that was pre-
warmed to 37 °C and incubated for one hour at 37 °C by shaking at 225 rpm. After that, 
appropriate amounts of bacteria were plated on agar plates containing kanamycin (50 
µg/ml) and let to incubate at 37 °C overnight.  
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On the next day, 57 bacterial colonies from each transformation reaction were inoculated 
in separate wells on PlateSeq Kit Clone agar plates from Eurofins Genomics. These plates 
were let to incubate further at 37 °C degrees overnight and on the next day they were sent 
to Eurofins to be sequenced. 
 
4.6 Statistical analysis 
The data received from NovoCyte was firstly analysed by FlowJo-Win64-10.7.1 to obtain 
the mean GFP loss (%) for each subclone from every reporter construct. The means of 
the experimental reporter constructs where then compared with GraphPad Prism (version 
9.0.2) to their positive controls. P-values for the differences were calculated with Mann-
Whitney test. From the analysis of the data, subclones with GFP loss greater than 95 % 
were excluded.  
Sequencing analysis was done with SnapGene (version 3.3.4) where the sequenced data 
was aligned with the original reporters and the number, type and location of mutations 
were collected manually. These were then used to calculate the frequency of mutations 
and analyse the mutation distribution along the reporter genes with the help of Microsoft 
Excel. P-value for studying the strand bias of the mutations was calculated with Fisher’s 
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6. List of abbreviations 
AID   activation-induced cytidine deaminase 
BER  base excision repair 
Bsr   blasticidin resistance gene 
CSR   class switch recombination 
DIVAC  diversification activator 
FACS   fluorescence-activated cell sorting 
G4   G-quadruplex 
GC  germinal centre  
HSC  haematopoietic stem cell 
HTS   hypermutation targeting sequence 
Ig   immunoglobulin 
IgH   immunoglobulin heavy chain 
IgL   immunoglobulin light chain 
IgS  immunoglobulin switch region 
IgV  immunoglobulin variable region 
IRES   internal ribosome entry site 
MMR  mismatch repair 
MZ  marginal zone 
PCNA  proliferating cell nuclear antigen 
RSV   Rous sarcoma virus 
SHM   somatic hypermutation 
ssDNA  single-stranded DNA 
TSS  transcription start site 
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Complete list of primers used 
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Primer name Primer sequence (5' --> 3') 
























Amplifying T2A + DsRED insert from pX458-DsRed vector 
T2A_DsRED_F GGCAGTGGAGAGGGCAGA 
T2A_DsRED_R CTACAGGAACAGGTGGTGGC 



















Polymerase chain reaction setups used 
 
Long DNA fragments 
Temperature (°C) Time Cycles 
98 30 s 1 
98 5 s 
32 68/72 20 s 
72 14 min 
72 2 min 1 
10 hold ∞ 
 
Short DNA fragments 
Temperature (°C) Time Cycles 
98 30 s 1 
98 5 s 
32 68/72 20 s 
72 15 s 
72 2 min 1 
10 hold ∞ 
 
DT40 genomic DNA 
Temperature (°C) Time Cycles 
98 30 s 1 
98 5 s 
32 68 20 s 
72 45 s 
72 2 min 1 
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